| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |